Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Pharmaceutical and Device
ASCO Policy for Relationships with Companies and How European Associations…
Over the last ten years, European conferences have exploded with increased attendance while US conferences have shriveled. One…
Pharmaceutical Patient Assistance Programs Expand throughout the World
Over the last few months, several pharmaceutical companies have announced new donations and programs regarding vaccines, as well…
Physician Payment Sunshine Act: Pfizer Grants Opts for Supporting Only…
This week, Pfizer, Inc. announced a change to its continuing education (CE) and continuing medical education (CME) policies in…
Generic Manufacturers Report Patent Settlements Saved the US Healthcare…
According to an analysis conducted for the Generic Pharmaceutical Association (GPhA), generic pharmaceuticals launched prior to…
DOJ Probing International Pharmaceutical Manufacturing
Earlier this year, we noted that a new enforcement focus for the U.S. Department of Justice (DOJ) will be increased oversight to…
PhRMA Report: Over 5400 Medicines in Development and 70% are First in Class
According to a report released by PhRMA, companies have more than 5,400 medicines in development globally, and more than 70% of…
DOJ to Target Pharma and Device Current Good Manufacturing Practices (cGMP)…
Over the last several years, we have written extensively about the ongoing government prosecution of pharmaceutical and medical…
Industry, Academic, Foundation and Government Alliances Continue in Early…
As promised, we are continuing to provide coverage of newly announced or recently discovered collaborations between industry,…
More Industry Academic Alliances
We recently covered Twenty Industry-Academic Alliances in 2012. In the past, we have also written extensively about other…
The Supreme Court and “Pay for Delay:” The Potential Impact on…
In early December of last year, the U.S. Supreme Court agreed to hear a case to decide whether agreements between brand-name…